Eloisa Jantus-Lewintre
Eloisa Jantus-Lewintre
Universidad Politécnica de Valencia
Verified email at
Cited by
Cited by
Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer
U Malapelle, R Sirera, E Jantus-Lewintre, P Reclusa, S Calabuig-Fariñas, ...
Expert review of molecular diagnostics 17 (3), 209-215, 2017
Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups
DA MacIntyre, B Jimenez, EJ Lewintre, CR Martín, H Schäfer, ...
Leukemia 24 (4), 788-797, 2010
Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer
D Ajona, MJ Pajares, L Corrales, JL Perez-Gracia, J Agorreta, MD Lozano, ...
Journal of the National Cancer Institute 105 (18), 1385-1393, 2013
Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure
ER Perna, SM Macı́n, JPC Canella, PM Alvarenga, NG Rı́os, R Pantich, ...
International journal of cardiology 99 (2), 253-261, 2005
Facilitated anion transport induces hyperpolarization of the cell membrane that triggers differentiation and cell death in cancer stem cells
V Soto-Cerrato, P Manuel-Manresa, E Hernando, S Calabuig-Farinas, ...
Journal of the American Chemical Society 137 (50), 15892-15898, 2015
Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer
R Sirera, RM Bremnes, A Cabrera, E Jantus-Lewintre, E Sanmartín, ...
Journal of Thoracic Oncology 6 (2), 286-290, 2011
Large scale, prospective screening of EGFR mutations in the blood of advanced NSCLC patients to guide treatment decisions
C Mayo-de-Las-Casas, N Jordana-Ariza, M Garzón-Ibañez, A Balada-Bel, ...
Annals of Oncology 28 (9), 2248-2255, 2017
Circulating tumor cells versus circulating tumor DNA in lung cancer—which one will win?
S Calabuig-Farinas, E Jantus-Lewintre, A Herreros-Pomares, C Camps
Translational lung cancer research 5 (5), 466, 2016
Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)
C Rolfo, AF Cardona, M Cristofanilli, L Paz-Ares, JJD Mochon, I Duran, ...
Critical Reviews in Oncology/Hematology 151, 102978, 2020
Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer
L Puchades-Carrasco, E Jantus-Lewintre, C Pérez-Rambla, ...
Oncotarget 7 (11), 12904, 2016
Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer
A Herreros-Pomares, JD de-Maya-Girones, S Calabuig-Fariñas, R Lucas, ...
Cell death & disease 10 (9), 660, 2019
Evaluation of NGS and RT-PCR methods for ALK rearrangement in European NSCLC patients: results from the European Thoracic Oncology Platform Lungscape Project
I Letovanec, S Finn, P Zygoura, P Smyth, A Soltermann, L Bubendorf, ...
Journal of Thoracic Oncology 13 (3), 413-425, 2018
Combined VEGF-A and VEGFR-2 concentrations in plasma: diagnostic and prognostic implications in patients with advanced NSCLC
E Jantus-Lewintre, E Sanmartín, R Sirera, A Blasco, JJ Sanchez, M Tarón, ...
Lung Cancer 74 (2), 326-331, 2011
Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer
J García-Foncillas, J Tabernero, E Élez, E Aranda, M Benavides, ...
British journal of cancer 119 (12), 1464-1470, 2018
The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patients
C Camps, E Jantus-Lewintre, A Cabrera, A Blasco, E Sanmartín, ...
Lung Cancer 72 (3), 365-369, 2011
Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping
J Zugazagoitia, I Ramos, JM Trigo, M Palka, A Gómez-Rueda, ...
Annals of Oncology 30 (2), 290-296, 2019
MicroRNAs: promising new antiangiogenic targets in cancer
S Gallach, S Calabuig-Fariñas, E Jantus-Lewintre, C Camps
BioMed research international 2014, 2014
Blockade of the complement C5a/C5aR1 axis impairs lung cancer bone metastasis by CXCL16-mediated effects
D Ajona, C Zandueta, L Corrales, H Moreno, MJ Pajares, ...
American journal of respiratory and critical care medicine 197 (9), 1164-1176, 2018
High levels of troponin T are associated with ventricular remodeling and adverse in-hospital outcome in heart failure
ER Perna, SM Macin, JPC Canella, PM Alvarenga, RE Pantich, NG Rios, ...
Medical Science Monitor 10 (3), CR90-CR95, 2004
Update on biomarkers for the detection of lung cancer
E Jantus-Lewintre, M Usó, E Sanmartín, C Camps
Lung Cancer: Targets and Therapy, 21-29, 2012
The system can't perform the operation now. Try again later.
Articles 1–20